کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3253766 | 1207153 | 2013 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Nueva insulina basal de acción ultralenta: insulina degludec
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
غدد درون ریز، دیابت و متابولیسم
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Insulin degludec is a new generation of ultra-long acting insulin with a unique mechanism of absorption. The aim of this work is to review the pharmacological characteristics of insulin degludec, as well as the efficacy and safety results obtained during its clinical development, currently in phase iii. The main differential characteristics of insulin degludec compared with long acting insulin analogues currently available are based on its pharmacological properties. Insulin degludec has an ultra-long (> 24 h), stable and peak-less action profile. These properties provide insulin degludec with a safety profile with a reduced risk of nocturnal hypoglycaemia, without compromising blood glucose control which is similar to insulin glargine. In patients with type 2 diabetes mellitus, insulin degludec could be administered at flexible dosing intervals of 8 h to 40 h.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Avances en DiabetologÃa - Volume 29, Issue 1, JanuaryâFebruary 2013, Pages 4-11
Journal: Avances en DiabetologÃa - Volume 29, Issue 1, JanuaryâFebruary 2013, Pages 4-11
نویسندگان
Rafael Simó,